OneOncology Research Network Presents 23 Studies at ASCO Annual Meeting

Strategic Insights -

Physicians affiliated with OneOncology partner practices, and the OneOncology Research Network (OneR), are presenting 23 research abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025, May 30-June 3. The selected studies reflect the deep commitment of OneR investigators to advancing cancer care across independent community practices nationwide, covering cutting-edge treatments, trial inclusivity, and patient accessibility. Two abstracts have been chosen as "Best of ASCO" for their significant impact on cancer care, including new treatment results for follicular lymphoma and long-term outcomes for a targeted therapy in leukemia.

Key Takeaways:

  • Two OneR abstracts have been selected as "Best of ASCO" at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025.
  • The selected studies cover a wide range of cancers, including lymphoma, lung cancer, head and neck cancer, bladder cancer, and rare tumor syndromes.
  • Research includes cutting-edge treatments, efforts to make trials more inclusive and accessible for all patients, and real-world data from community-based practices.
  • OneR is a national site management organization, bringing operational expertise and centralized services to efficiently deliver multi-center clinical research across a growing network of community oncology practices.
  • The OneOncology Research Network aims to connect leading investigators, clinical trials, and real-world data to improve patient access to cutting-edge cancer care, regardless of location.
  • The partnership between OneOncology and OneR reinforces the strength of science in independent community-based practices, offering real hope for patients and improved access to clinical trials.

Statistics:

  • 23 research abstracts will be presented by OneOncology partner practices and OneR investigators at the ASCO Annual Meeting 2025.
  • 2 OneR studies have been chosen as "Best of ASCO", highlighting significant progress in treating follicular lymphoma and chronic lymphocytic leukemia.
  • OneR has a growing network of community oncology practices, with over 1,750 cancer care providers serving approximately 1 million patients across more than 565 sites of care nationwide.
  • The OneOncology Research Network aims to support over 1 million patients annually across the United States.

Sources:

  • OneOncology, LLC, "Two OneR Studies Selected as Best of ASCO, Including New Treatment Results for Follicular Lymphoma and Long-Term Outcomes for a Targeted Therapy in Leukemia" (PRNewswire, May 28, 2025)
  • OneOncology, LLC, "OneOncology" (OneOncology, LLC, n.d.)
  • OneOncology, LLC, "About OneOncology" (OneOncology, LLC, n.d.)